AARDVARK THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AARDVARK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $3.00K, a 25.00% decline year-over-year.
- AARDVARK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $4.00K, a 96.04% decline year-over-year.
- AARDVARK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $79.00K, a 39.69% decline year-over-year.
- AARDVARK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $171.00K, a 1.18% increase year-over-year.
- AARDVARK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $355.00K, a 18.33% increase from fiscal 2024.
- AARDVARK THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $300.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-08-11 | $257.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-07 | $258.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $355.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $171.00K 10-Q · filed 2025-11-13 | $407.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $4.00K 10-Q · filed 2026-08-11 | $405.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $101.00K 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $300.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $169.00K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |